Welcome to the world of facts and news: Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

from RSS Feeds : RSS Feed - NDTV Gadgets360.com https://ift.tt/2XjoJ5n
By -
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Yellow.ai deploys 30% of global generative AI bots domestically

While markets like the US are mostly using GenAI for customer support in a bid to cut costs, India Inc. is using them as an opportunity to g...